Effective treatment for Male Erection problems

About Viagry Sildenafil tablets

Pill Viagra Sildenafil is one of the most popular treatments for Erectile dysfunction.Developed by Pfizer Pharmaceuticals, pill awareness bar has been approved by the u.s. FDA to 27, 1998. Viagra Sildenafil became instant hit with the annual sales Viagra Sildenafil in the period 1999-2001 exceeded 1 billion dollars.

Revolutionary change the perception of drug companies towards sex and impotence.The men who were until now silently suffer from Erectile dysfunction began to seek the prescription Viagra from their doctors Much Credit for revolution. points to a massive advertising campaign launched by Pfizer, which provided information on Erectile dysfunkci and promotion of the tablets Sildenafil its effective treatment Viagry. television campaign, please respect the former United States Senator Bob Dole and football star Pelé and immediately caught the attention of the masses.

The problem of male Erection

Problem with Erection in men is defined as the inability to achieve and maintain the erection penis that is strong enough to have sex with men while some men come into contact. are unable to achieve erection at all, others may lose their erection during intercourse. Consistent inability to achieve or maintain a firm erection sufficient for erectile dysfunction, impotence or means.

The majority of men at some point in the life of suffering from problems, however, the condition of the erection is more common among the elderly are more likely to suffer from conditions which may impede the physiological processes that can help you obtain erections man.

The reasons for preferring, Viagra Erection cure the problem

Before the start of the part of the treatment methods only Viagry, which are available for the treatment of Erection problems, vacuum pumps, horses and surgical implants injection.These methods were uncomfortable and, therefore, chose men lead through its Erection problems instead of finding a quiet uncomfortable treatment.

However, the opening of the Viagry changed remarkably. Viagry Sildenafil Tablets gave men the erection of freedom problems have successful sexual intercourse by strcit pill one hour before the anticipated sexual activity has been demonstrated. Viagra safe and effective in numerous clinical trials and has also been approved by the FDA.The men felt certainty with regard to Viagra and were satisfied with the results promised.

Long five years Viagra Sildenafil tablets enjoyed complete impotence drug treatment as monopoly. in 2003, saw the placing additional treatment drug impotence Levitra, Cialis and Viagra Cialis when remains active only 4 hours, offers a active period of 36 hours, many men still prefer to take Viagra. This is because the tests, drugs, and have developed a bond with him, Cialis and Levitra are. therefore, the search is hard to terminate the loyalty that men on Viagra.

It is not who should Viagra?

Viagra Sildenafil is the only drug prescription and therefore only a doctor can decide on the suitability of the drugs we have, however, you can. some general guidance that States which do not take Viagra-

about people with normal sexual function is not take Viagra
about people taking medications with nitrates in any form is not appropriate to use Viagra
about people taking medication alpha-blocker take Viagra with caution
about People not use Viagra for recreational purposes could be dangerous

This article contains important information about sildenafil, know more information about Erectile dysfunkci and how sildenafil Viagra helps in the treatment of impotence or Erectile dysfunction.

ErecAid Supplemental: Effective Erectile Dysfunction Treatment

Plethora Solutions Holdings PLC (“Plethora”, AIM: PLE), the specialist developer of products for the treatment and management of urological disorders, announces results of a study confirming the role its product, ErecAid, as a supplemental first line treatment for erectile dysfunction (ED). ErecAid is marketed through Plethora’s US subsidiary, Timm Medical Technologies, Inc. (“Timm Medical”, Minneapolis, MN).

The phosphodiesterase five inhibitors (PDE5i) such as Viagra and Cialis have become a major resource in the management of ED. Unfortunately, 30-50% of men report inadequate results with these oral medications. When patients fail to respond to the oral medications, physicians are often forced to consider more invasive and more complicated second line agents such as penile injections or urethral suppositories.

New data from a multi-center clinical trial led by investigators at Johns Hopkins School of Medicine demonstrate that use of the ErecAid vacuum erection device to augment PDE5i therapy can greatly improve patient satisfaction. Results of the study were presented at a recent North Central Sectional meeting of the American Urological Association.

Investigators at four separate study sites evaluated 69 men aged 36 to 82 with ED of diverse etiology who had responded inadequately to PDE5i therapy. Study subjects were allowed to continue use of PDE5i’s but were instructed to use the ErecAid device as an adjunct to their current oral medication. Study subjects were assessed using three validated measurements of erectile function and sexual satisfaction: the International Index of Erectile Function (IIEF-5), the Sexual Encounter Profile (SEP-2 and SEP-3) and the Global Patient Assessment Scale (GAPS).

After 4 weeks of supplemental treatment with ErecAid, the IIEF-5 score improved substantially from a baseline of 9.0 to 17.6 (p<0.001). Moreover, of the 34 subjects unable to achieve an erection satisfactory for intercourse at baseline (SEP-2 response of “no”), 27 subjects (79%) reported erections satisfactory for intercourse following the addition of ErecAid (p<0.001). Finally, of 42 subjects reporting no or slight response to PDE5i at baseline (GAPS responses of “not at all” or “slightly”), 31 (74%) reported moderate or great improvement (GAPS responses of “moderately” or “greatly”) at the end of the 4 week study (p<0.001).

According to Dr. Arthur Burnett, Professor of Urology at Johns Hopkins School of Medicine and the lead investigator of this trial, “This study confirms an earlier trial that many patients can achieve excellent results using ErecAid as an addition to oral PDE5i therapy. Based upon these results, I would encourage physicians treating ED to consider the importance of this approach in their treatment protocols and to discuss this option with their patients.”

This entry was posted on Wednesday, November 3rd, 2010 at 11:05 am and is filed under Impotence.
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

View the original article here